Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Global Briefing 2017 Including: Prostatic Stents And Catheter Ablation Devices Covering: Endo Health Solutions, Karl Storz, Lumenis, Olympus, Urologix, Boston Scientific

Published by The Business Research Company on 27th July 2017 | Ref: 505552 | This Report Is In Stock

$1000 | Single User
$1500 | Site License
$2000 | Enterprise License
$1000 | Single User
$1500 | Site License
$2000 | Enterprise License

Introduction

Benign prostatic hyperplasia (BPH) treatment devices market comprises of Benign Prostatic Hyperplasia (BPH) treatment devices that are used in the treatment of benign prostatic hyperplasia or benign prostatic hypertrophy, a condition of an enlarged prostate gland which causes blockade of urethra, the tube that carries urine from the bladder. These devices include prostatic stents and catheter ablation devices.

The global benign prostatic hyperplasia (BPH) treatment devices market was estimated to be around .6 billion as of 2016. The global benign prostatic hyperplasia (BPH) treatment devices made up around 10% of the overall nephrology and urology devices market in 2016. The benign prostatic hyperplasia (BPH) treatment devices market was the fourth largest market in the global nephrology and urology devices market in 2016.

Development of Minimally Invasive Treatments

Minimally-invasive surgery refers to nephrology and urology surgical techniques that limit the size of incisions needed thereby decreasing wound healing time, pain and risk of infection. Interventional instruments are directed through the body using catheters instead of making large incisions needed in traditional surgery. NeoTract Inc. developed the UroLift System treatment to treat benign prostatic hyperplasia in men. The procedure involves lifting and holding the enlarged prostate tissue to remove blockage to the urethra. In comparison to traditional surgical techniques, this involves no cutting, heating or removal of prostate tissue . New treatment is also developed for enlarged prostate which involves prostate artery embolization by inserting a catheter into the femoral artery in the thigh. This minimally invasive treatment offers men with an enlarged prostate an effective treatment that results in fewer side effects, reduced risk of urinary incontinence and bleeding compared to other BPH therapies whilst also offering a better quality of life.

Nephrology and urology device companies should invest in the development of minimally-invasive techniques to give patients a better quality of life. This would greatly help in capturing the high growth in this division.

Table of Contents

Table Of Contents

1. Introduction

2. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Characteristics

3. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Historic Growth

• Drivers Of The Market

• Restraints On The Market

4. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast Growth

• Drivers Of The Market

• Restraints On The Market

5. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Geography Split

6. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market As A Proportion of Nephrology and Urology Devices Market, 2016, By Region

7. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market As A Proportion of Nephrology and Urology Devices Market, 2016, By Country

8. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Segmentation

9. Benign Prostatic Hyperplasia (BPH) Treatment Devices Competitive Landscape

Endo Health Solutions

Karl Storz

Lumenis

Olympus

Urologix

10. Key Mergers And Acquisitions In The Benign Prostatic Hyperplasia (BPH) Treatment Devices Market

11. Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Trends And Strategies

Appendix

NAICS Definitions of Industry Covered In This Report

Research Methodology

Methodology

Data

Market Numbers

Competitor Market Share Data

Analysis

Verification Through Expert Interviews

Referencing

Note on Currency Conversions

Abbreviations

Currencies

Research Inquiries

The Business Research Company

Additional Details

Publisher

The Business Research Company

Publisher Information

Reference

505552 |

Number of Pages

35

Report Format

PDF

This report is published by The Business Research Company

Download Free Report Summary PDF

Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Global Briefing 2017 
Including: Prostatic Stents And Catheter Ablation Devices
Covering: Endo Health Solutions, Karl Storz, Lumenis, Olympus, Urologix, Boston Scientific [Updated: 27-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.